CFTR chloride channel is the molecular drug target for the treatment of secretory diarrhea. Screening CFTR inhibitors is the most important and basic part of anti-diarrheal drug development. The natural products are diversified both in the structure and the biological activity. In the discovery of drugs and leading compounds, natural products play a key role and become the main source of drug development. Natural products from foods and herbal plants are usually safe for low or no toxicity and side-effect in clinic. CFTR inhibitors which source of foods and traditional Chinese medicines are important of study and treatment of CFTR related diseases, as well as providing a basis for the modern drug discovery in the natural product resources.

Publication Date


First Page


Last Page





[1] Sheppard D N, Welsh M J. Structure and function of the CFTR chloride channel[J]. Physiological Reviews, 1999, 79(1Suppl):S23~45.
[2] Anderson M P, Gregory R J, Thompson S, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity[J]. Science, 1991, 253(5 016):202~205.
[3] Walker C L F, Rudan I, Liu Li, et al. Global burden of childhood pneumonia and diarrhea[J]. Lancet, 2013, 381(9 875):1 405~1 416.
[4] Thiagarajah J R, Verkman A S. CFTR inhibitors for treating diarrheal disease[J]. Clinical Pharmacology & Therapeutics, 2012, 92(3):287~290.
[5] Ma Tong-hui, Thiagarajah J H, Sonawane N D, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion[J]. Journal of Clinical Investigation, 2002, 110(11):1 651~1 658.
[6] Zhang Wei-qiang, Fujii N, Naren A P. Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas[J]. Future Medicinal Chemistry, 2012, 4(3):329~345.
[7] Frampton J E. Crofelemer: A review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy[J]. Drugs, 2013, 73(10):1 121~1 129.
[8] Ubillas R, Jolad S D, Bruening R C, et al. SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago)[J]. Phytomedicine International Journal of Phytotherapy & Phytopharmacology, 1994, 1(2):77~106.
[9] Tradtrantip L, Namkung WVerkman A S. Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels[J]. Molecular Pharmacology, 2010, 77(1):69~78.
[10] Crutchley R D, Miller J, Garey K W. Crofelemer, a novel agent for treatment of secretory diarrhea[J]. Annals of Pharmacotherapy, 2010, 44(5):878~884.
[11] Jessica C, Anne T, Rustin C, et al. Crofelemer for the treatment of secretory diarrhea[J]. Expert Review of Gastroenterology & Hepatology, 2012, 6(1):17~23.
[12] Fischer H, Machen TE, Widdicombe JH, et al. A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells[J]. Journal of Ethnopharmacology, 2004, 93(2/3):351~357.
[13] Ma Cheng-jun, Li Gui-sheng, Zhang Da-lei, et al. One step isolation and purification of liquiritigenin and isoliquiritigenin from Glycyrrhiza uralensis Risch. using high-speed counter-current chromatography[J]. Journal of Chromatography A, 2005, 1 078(1):188~192.
[14] Motohiro K, Yoshiko S, Yoichi M, et al. Isoliquiritigenin inhibits the growth of prostate cancer[J]. European Urology, 2003, 43(5):580~586.
[15] Yamamoto S, Aizu E, Jiang Hong, et al. The potent anti-tumor-promoting agent isoliquiritigenin[J]. Carcinogenesis, 1991, 12(2):317~323.
[16] Sun Jian-jun, Li Chang-dong, Li Zhi-yun. Research advances of cerebral protection by isoliquiritigenin[J]. Progress in Modern Biomedicine, 2012,12(14):2 791~2 793
[17] Muanprasat C, Sirianant L, Soodvilai S, et al. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease[J]. Journal of Pharmacological Sciences, 2012, 118(1):82~91.
[18] Claudio G, Paolo S, Enrica C, et al. Metabolism of stevioside and rebaudioside a from stevia rebaudiana extracts by human microflora[J]. J. Agric. Food Chem., 2003, 51(22):6 618~6 622.
[19] Pariwat P, Homvisasevongsa S, Muanprasat C, et al. A natural plant-derived dihydroisosteviol prevents cholera toxin-induced intestinal fluid secretion[J]. Journal of Pharmacology & Experimental Therapeutics, 2008, 324(2):798~805.
[20] Chaowalit Y, Chatchai M, Anna-Rachel G, et al. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease[J]. Biochemical Pharmacology, 2014, 88(3):412~421.
[21] Yuajit C, Homvisasevongsa S, Chatsudthipong L, et al. Steviol reduces MDCK cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation[J]. Plos One, 2013, 8(3):4 422~4 427.
[22] Dillinger T L, Barriga P, Escárcega S, et al. Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate[J]. Journal of Nutrition, 2000, 130(8):2 057S~2 072S.
[23] Maximilian S, Helmut S, Beate I, et al. Cocoa-related flavonoids inhibit CFTR-mediated chloride transport across T84 human colon epithelia[J]. Journal of Nutrition, 2005, 135(10):2 320~2 325.
[24] Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols[J]. Journal of Nutrition, 2000, 130(8Suppl):2 073S~2 085S.
[25] Holt R R, Lazarus S A, M Cameron S, et al. Procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa[J]. American Journal of Clinical Nutrition, 2002, 76(4):798~804.
[26] Broach J R, Thorner J. High-throughput screening for drug discovery[J]. Nature, 1996, 384(6 604):14~16.
[27] 肖小河, 黄璐琦, 马小军. 论中药和中药现代化的新内涵及其意义[J]. 中国中药杂志, 2003, 28(3): 282~286.
[28] 章朔.中药材标准建设[J].中国现代中药, 2007, 9(6): 34~35.
[29] 濮润, 关镇和, 苏月, 等. 浅议我国医药产业研发现状及未来发展建议[J]. 中国生物工程杂志, 2014, 34(7): 114~119.
[30] Ikezoe T, Sophie S Chen, Tong Xian-jun, et al. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells[J]. International Journal of Oncology, 2003, 23(4):1 187~1 193.
[31] Kwan H Y, Yang Zhi-jun, Fong Wang-fun, et al. The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells[J]. Journal of Gastroenterology, 2013, 48(2):182~192.
[32] Bae S, Lee E J, Lee J H, et al. Oridonin protects HaCaT keratinocytes against hydrogen peroxide-induced oxidative stress by altering microRNA expression[J]. International Journal of Molecular Medicine, 2013, 33(1):185~193.
[33] Luan Jian, Zhang Yao-fang, Yang Shuang, et al. Oridonin: A small molecule inhibitor of cystic fibrosis transmembrane conductance regulator (CFTR) isolated from traditional Chinese medicine[J]. Fitoterapia, 2015, 100:88~94.
[34] Zhang Yao-fang, Yu Bo, Sui Yu-jie, et al. Identification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from chinese medicinal plants[J]. Plos One, 2014, 9(4):1~10.
[35] 陈波, 俞惠新, 谭成, 等. 白藜芦醇及其衍生物抗氧化抗肿瘤活性研究[J]. 食品与机械, 2007, 23(4): 52~55.
[36] Pallàs M, Junyent F, Verdaguer E, et al. Aging control with resveratrol[J]. Drug Discovery Today Therapeutic Strategies, 2010, 7(3):51~56.
[37] Bertelli A A, Giovannini L, Giannessi D, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine[J]. International Journal of Tissue Reactions, 1995, 17(1):1~3.
[38] Yu Bo, Zhang Yao-fang, Sui Yu-jie, et al. Potentiation of mutant CFTR Cl- channel currents by the naturally occurring stilbene compound resveratrol[J]. Die Pharmazie, 2013, 68(11):877~881
[39] Chen Lei, Yu Bo, Zhang Yao-fang, et al. Bioactivity-guided fractionation of an antidiarrheal Chinese herb rhodiola kirilowii (regel) maxim reveals (-)-epicatechin-3-gallate and (-)-epigallocatechin-3-gallate as inhibitors of cystic fibrosis transmembrane conductance regulator[J]. Plos One, 2015, 10(3):1~12.
[40] Namkung W, Thiagarajah J R, Phuan P W, et al. Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea[J]. Faseb Journal, 2010, 24(11):4 178~4 186.
[41] Aijing S, Karin H, Linda N, et al. Placebo-controlled trials of Chinese herbal medicine and conventional medicine-comparative study[J]. International Journal of Epidemiology, 2007, 36(5):1 086~1 092.
[42] Zhang Fang, Kong Lin-lin, Zhang Yi-ye, et al. Evaluation of impact on health-related quality of life and cost effectiveness of Traditional Chinese Medicine: a systematic review of randomized clinical trials[J]. Journal of Alternative & Complementary Medicine, 2012, 18(12):1 108~1 120.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.